Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Lewy Body Dementia Market Expected To Reach $1.68 Billion By 2030 At 6.9% CAGR

The market for lewy body dementia has demonstrated robust expansion, projecting an increase from $1.2 billion in 2025 to $1.29 billion in 2026, fueled by a compound annual growth rate of 7.2%. This notable growth trajectory is underpinned by several key factors that were influential during the preceding period, including the demographic shift towards an older populace, heightened awareness surrounding various forms of dementia, the escalating adoption of neurological assessment tools, a widening scope of hospital-based diagnostic capabilities, and an intensified clinical emphasis on addressing cognitive deterioration.

The global lewy body dementia market is poised for significant expansion, projected to reach $1.69 billion by 2030, exhibiting a compound annual growth rate of 6.9% during the forecast period. This anticipated growth is fueled by several key factors including enhanced diagnostic precision, an increasing incidence of neurological ailments, the proliferation of specialized treatment centers, robust support systems for patients and their caregivers, and a greater allocation of healthcare resources towards dementia management. Within this timeframe, notable market trends are expected to emerge, such as a higher occurrence of neurodegenerative conditions, heightened public and professional awareness leading to earlier identification of lewy body dementia, a growing demand for precise diagnostic tools to differentiate it from other conditions, greater adoption of medications targeting specific symptoms, and an escalating requirement for comprehensive long-term care and ongoing disease management strategies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21213&type=smp

Lewy Body Dementia Market Growth Drivers And Industry Catalysts

The escalating incidence of neurological conditions is poised to fuel the expansion of the lewy body dementia market, as these disorders encompass a spectrum of ailments impacting the brain’s integrity and operational capacity, resulting in diminished cognitive abilities, impaired memory, and altered conduct. Factors such as an aging populace, inherent genetic sensitivities, and external environmental elements contribute to the growing prevalence of these brain afflictions. This heightened occurrence of neurological issues consequently elevates the need for more effective therapeutic interventions and timely identification of lewy body dementia, thereby stimulating scientific inquiry, financial investment, and innovative developments, ultimately accelerating progress in both the diagnostic and treatment paradigms for LBD. Illustratively, as reported by the World Federation of Neurology in October 2023, over 40% of the worldwide population currently experiences neurological ailments, a figure projected to nearly double by the year 2050. Consequently, the increasing burden of brain-related disorders will serve as a significant catalyst for the lewy body dementia market’s growth.

Lewy Body Dementia Market Segment Analysis And Revenue Opportunities

The lewy body dementia market covered in this report is segmented –

1) By Diagnosis: Clinical Diagnosis, Biomarker-Based Diagnosis

2) By Medication: Cholinesterase Inhibitors, Antipsychotics, Antidepressants, Other Medications

3) By End-User: Hospitals, Specialty Clinics, Long-Term Care Facilities, Other End-Users

Subsegments:

1) By Clinical Diagnosis: Neuropsychological Testing, Neurological Examination, Medical History Review, Cognitive Function Assessment

2) By Biomarker-Based Diagnosis: Cerebrospinal Fluid (CSF) Biomarkers, Imaging Biomarkers (PET, MRI)

#Lewy Body Dementia Market Trends Influencing Long-Term Demand

Within the lewy body dementia sector, prominent players are prioritizing augmented investment in R&D to pioneer superior treatments for neurodegenerative conditions. This commitment to research entails allocating substantial capital, time, and human ingenuity toward scientific endeavors designed to unearth novel understandings, formulate groundbreaking therapies, or refine existing therapeutic approaches, all in service of advancing patient care. As an illustration of this commitment, the National Institute on Aging, a U.S. federal entity, allocated $21 million in March 2023 to bolster drug discovery research specifically targeting Lewy Body Dementia (LBD). Furthermore, clinical investigations are underway, with scientists at the University of Miami Miller School of Medicine commencing a Phase 2b trial for neflamapimod, building upon promising preliminary findings.

Lewy Body Dementia Market Leading Players Shaping Industry Direction

Major companies operating in the lewy body dementia market are Eli Lilly and Company, Mayo Foundation for Medical Education and Research, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Georgetown University Medical Center, Alzheimer’s Society, BioArctic AB, Annovis Bio Inc., Sun Pharma Advanced Research Company Limited, Voyager Therapeutics Inc., Cognition Therapeutics, Athira Pharma, Allergan plc, Inhibikase Therapeutics, CuraSen Therapeutics Inc., CervoMed Inc., AC Immune SA, ProMIS Neurosciences Inc., Aptinyx Inc., EIP Pharma Inc.

Access The Complete Lewy Body Dementia Market Report:

https://www.thebusinessresearchcompany.com/report/lewy-body-dementia-global-market-report

Lewy Body Dementia Market Regional Outlook: Where Are The Largest Opportunities Located?

North Americawas the largest region in the lewy body dementia market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the lewy body dementia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model